NFE2L2 and cancer: The two-site binding mode is supported by the observation that somatic mutations in various cancer cells occur with very high-frequency in the DLGex and ETGE motifs of NRF2 (Shibata et al., 2008; Cancer Genome Atlas Research, 2012).